114 related articles for article (PubMed ID: 711612)
1. Action of cefoxitin and cefamandole on human neutrophil function.
Majeski JA; Morris MJ; Alexander JW
J Antibiot (Tokyo); 1978 Oct; 31(10):1059-62. PubMed ID: 711612
[TBL] [Abstract][Full Text] [Related]
2. Lack of correlation between beta-lactamase production and susceptibility to cefamandole or cefoxitin among spontaneous mutants of Enterobacteriaceae.
Ott JL; Turner JR; Mahoney DF
Antimicrob Agents Chemother; 1979 Jan; 15(1):14-9. PubMed ID: 311615
[TBL] [Abstract][Full Text] [Related]
3. In vitro effect of cefoxitin on phagocytic function and antibody-dependent cellular cytotoxicity in human neutrophils.
Rodriguez AB; Barriga C; De la Fuente M
Comp Immunol Microbiol Infect Dis; 1993 Jan; 16(1):37-50. PubMed ID: 8440085
[TBL] [Abstract][Full Text] [Related]
4. The effect of beta-lactamase stability, penetration, and target affinity on the activity of cefazolin, cefamandole, cefoxitin, and cefuroxime.
Harper PB
Clin Ther; 1984; 6(3):310-24. PubMed ID: 6609771
[TBL] [Abstract][Full Text] [Related]
5. Sensitivity of gentamicin-resistant Enterobacteriaceae to cefamandole and cefoxitin.
Rosenthal SL; Freundlich LF; Quraishi MA
Chemotherapy; 1979; 25(3):157-61. PubMed ID: 456076
[TBL] [Abstract][Full Text] [Related]
6. ["In vitro" activity of cefamandole, cefalotin, cefoxitin and cefuroxim against enterobacteria and Staphylococcus aureus isolated in hospital (author's transl)].
Thabaut A; Durosoir JL; Saliou P
Pathol Biol (Paris); 1979 Dec; 27(10):649-54. PubMed ID: 395496
[TBL] [Abstract][Full Text] [Related]
7. Comparative in-vitro activity of cefamandole, cefoxitin, cefuroxime and cephalothin.
Brorson JE; Norrby R
Scand J Infect Dis Suppl; 1978; (13):88-93. PubMed ID: 278150
[No Abstract] [Full Text] [Related]
8. Comparative in vitro activity of 8 cephalosporins on 109 strains of Neisseria gonorrhoeae and 60 strains of Neisseria meningitidis.
Thabaut A; Durosoir JL; Saliou P
Chemotherapy; 1981; 27 Suppl 1():19-24. PubMed ID: 6265159
[TBL] [Abstract][Full Text] [Related]
9. Drug therapy reviews: antimicrobial spectrum, pharmacology and therapeutic use of cefamandole and cefoxitin.
Fraser DG
Am J Hosp Pharm; 1979 Nov; 36(11):1503-8. PubMed ID: 391032
[No Abstract] [Full Text] [Related]
10. Comparison between agar and broth minimum inhibitory concentrations of cefamandole, Cefoxitin, and cefuroxime.
Rylander M; Brorson JE; Johnsson J; Norrby R
Antimicrob Agents Chemother; 1979 Apr; 15(4):572-9. PubMed ID: 464588
[TBL] [Abstract][Full Text] [Related]
11. Correlation of in vitro susceptibility with in vivo efficacy in mice for cefoxitin in comparison with cephalosporins.
Miller AK; Celozzi E; Pelak BA; Birnbaum J; Stapley EO
J Antimicrob Chemother; 1979 Sep; 5(5):569-79. PubMed ID: 315403
[TBL] [Abstract][Full Text] [Related]
12. Effect of cefamandole, cefuroxime and cefoxitin on yeast fecal flora of surgical patients.
Thomakos N; Maraki S; Liakakos T; Macheras A; Kanavaki S; Marinis E; Sehas M; Margioris AN; Samonis G
Chemotherapy; 1998; 44(5):324-7. PubMed ID: 9732147
[TBL] [Abstract][Full Text] [Related]
13. Cefuroxime, cefamandole, cefoxitin, and cephalothin in vitro susceptibility tests: reassessment of the "class representative" concept, confirmation of disk interpretive criteria, and proposed quality control guidelines.
Barry AL; Jones RN; Thornsberry C
Am J Clin Pathol; 1983 Aug; 80(2):182-9. PubMed ID: 6881092
[TBL] [Abstract][Full Text] [Related]
14. Resistance to cefamandole: derepression of beta-lactamases by cefoxitin and mutation in Enterobacter cloacae.
Gootz TD; Sanders CC; Goering RV
J Infect Dis; 1982 Jul; 146(1):34-42. PubMed ID: 6979593
[TBL] [Abstract][Full Text] [Related]
15. Comparison of BL-S786 with cephalothin, cefamandole and cefoxitin in vitro and in treatment of experimental infections in mice.
Goering RV; Sanders CC; Sanders W
J Antibiot (Tokyo); 1978 Apr; 31(4):363-72. PubMed ID: 306989
[TBL] [Abstract][Full Text] [Related]
16. [3 new cephalosporins: cefamandole, cefuroxime, cefoxitin].
Mirimanoff RO; Héraïef E
Rev Med Suisse Romande; 1981 Dec; 101(12):963-8. PubMed ID: 7342276
[No Abstract] [Full Text] [Related]
17. Inhibitory concentrations of cefoperazone, cefazolin, cefamandole, cephaloridine, and cefoxitin for 300 gram-negative clinical isolates.
Trabulsi LR; Pereira da Silva Almada N; Marques LR
Clin Ther; 1980; 3(Spec Issue):145-8. PubMed ID: 6446390
[No Abstract] [Full Text] [Related]
18. Effects of cefotetan disodium, cefoxitin, cefazolin, and cefotaxime in vitro on polymorphonuclear leukocytes from patients with leukopenia and severe pelvic inflammatory disease.
Ford LC; Nilsson JD; Hammill HA
Am J Obstet Gynecol; 1988 Mar; 158(3 Pt 2):744-5. PubMed ID: 3162655
[TBL] [Abstract][Full Text] [Related]
19. [Comparative study of the "in vitro" sensitivity of cefoxitin and cephalosporins].
Torres A; Aguirre M; Ales JM
Rev Clin Esp; 1979 Nov; 155(4):249-52. PubMed ID: 542674
[No Abstract] [Full Text] [Related]
20. Methodological implications of testing anaerobe susceptibility to cephalosporins (cefazolin, cefamandole, cefoxitin).
Krasemann C; Werner H; Hildenbrand G; Benning M; Brandt U; Ungerechts J
Infection; 1980; 8 Suppl 2():S182-6. PubMed ID: 6969693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
